425 results on '"Jakob, Thilo"'
Search Results
2. Messages for patients and relatives from the 2021 update of the guideline on acute therapy and management of anaphylaxis
3. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI
4. Penicillin-Toleranzinduktion in der Schwangerschaft: Allergologische Stellungnahme zur Empfehlung der aktuellen Leitlinie Diagnostik und Therapie der Syphilis (AWMF-Register-Nr. 059-002)
5. Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA)
6. Expert consensus on practical aspects in the treatment of chronic urticaria
7. Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE)
8. Marker allergens in Hymenoptera venom allergy — Characteristics and potential use in precision medicine
9. Anaphylaxie-Risiko bei der COVID-19-Impfung: Empfehlungen für das praktische Management
10. Atopische Keratokonjunktivitis: Pathophysiologie, Klinik und potenzielle neue Therapiekonzepte.
11. A WAO — ARIA — GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020
12. Healthcare provision for insect venom allergy patients during the COVID-19 pandemic
13. Worldwide perspectives on venom allergy
14. Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry
15. ARIA guideline 2019: treatment of allergic rhinitis in the German health system
16. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels
17. Efficacy and safety of on‐demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial.
18. Correction to “ARIA guideline 2019: treatment of allergic rhinitis in the German health system”
19. Lack of Type 2 Innate Lymphoid Cells Promotes a Type I-Driven Enhanced Immune Response in Contact Hypersensitivity
20. Characterization of the honeybee venom proteins C1q-like protein and PVF1 and their allergenic potential
21. Guideline on diagnostic procedures for suspected hypersensitivity to beta-lactam antibiotics: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Society of Allergology (AeDA), German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Austrian Society for Allergology and Immunology (ÖGAI), and the Paul-Ehrlich Society for Chemotherapy (PEG)
22. Development of subcutaneous allergen immunotherapy (part 2): preventive aspects and innovations
23. Evolution of subcutaneous allergen immunotherapy (part 1): from first developments to mechanism-driven therapy concepts
24. Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
25. Antigen 5 Allergens of Hymenoptera Venoms and Their Role in Diagnosis and Therapy of Venom Allergy
26. The Honeybee Venom Major Allergen Api m 10 (Icarapin) and Its Role in Diagnostics and Treatment of Hymenoptera Venom Allergy
27. Potential and limitations of epitope mapping and molecular targeting in Hymenoptera venom allergy.
28. Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy
29. Current state of follow-up care for patients with Hymenoptera venom anaphylaxis in southwest Germany: Major impact of early information
30. In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria.
31. The benefit of molecular diagnostics in allergic rhinitis
32. Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics
33. Correction to: Guideline for the diagnosis of drug hypersensitivity reactions
34. Component resolution reveals additional major allergens in patients with honeybee venom allergy
35. Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence
36. Component resolved diagnostics for hymenoptera venom allergy
37. Supportive care of patients with anaphylaxis — options and shortcomings: an assessment on behalf of the working group on anaphylaxis training and education (AGATE), Germany
38. Molecular allergy diagnostics using multiplex assays: methodological and practical considerations for use in research and clinical routine: Part 21 of the Series Molecular Allergology
39. Spiking with recombinant allergens to improve allergen extracts: benefits and limitations for the use in routine diagnostics: Part 19 of the Series Molecular Allergology
40. Molecular allergy diagnostics using IgE singleplex determinations: methodological and practical considerations for use in clinical routine: Part 18 of the Series Molecular Allergology
41. Performance evaluation of ImmunoCAP® ISAC 112: a multi-site study
42. Comparing sensitivity of Hymenoptera allergen components on different diagnostic assay systems: Comparing apples and oranges?
43. Stimulation of naïve B cells with a fusion protein consisting of FlaA and Bet v 1 induces regulatory B cells ex vivo.
44. Structural and functional analyses of antibodies specific for modified core N‐glycans suggest a role in TH2 responses.
45. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM)
46. Comparison of molecular and extract-based allergy diagnostics with multiplex and singleplex analysis
47. Cockroach, tick, storage mite and other arthropod allergies: Where do we stand with molecular allergy diagnostics?: Part 15 of the Series Molecular Allergology
48. Contact anaphylaxis after application of an herbal ointment containing phenonip: Case report
49. Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB 1/CB 2 receptors
50. Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.